Endocrine treatment consisted of multiple hormone replacement therapies: insulin for type 1 diabetes mellitus (despite marked glycemic variability and recurrent hypoglycemic episodes), oral prednisone for secondary adrenal insufficiency, and levothyroxine for secondary hypothyroidism. The gene discussed is INS; the disease is type 1 diabetes mellitus.